, Emmanuel Haffen (Service de Psychiatrie, CIC-1431 INSERM, p.25000

F. ;. Besançon and . De-neurosciences, Christophe Daudet, p.22

A. De-maignon, ;. Anglet, ). France, and L. Samalin, Jean-Christophe Chauvet-Gélinier (Psychiatry unit, department of neurosciences, university hospital, Psychiatric Disorders: from Resistance to Response Team, vol.7280, 21079.

, Psychiatric Disorders: from Resistance to Response Team

, Unité de recherche clinique intersectorielle en psychiatrie à vocation régionale Pierre Deniker du Centre Hospitalier Henri Laborit F-86022 France, Groupement De Recherche CNRS, vol.3557

, Dominique Drapier (Centre Hospitalier Guillaume Régnier, 108 avenue général leclerc 35 703 Rennes, Groupement De Recherche CNRS, vol.3557

, Jean-Marie Batail (Centre Hospitalier Guillaume Régnier, 108 avenue général leclerc 35 703 Rennes, EA 4712 Comportements et noyaux gris centraux, vol.1

, Maud Rotharmel (Service Hospitalo-Universitaire, EA 4712 Comportements et noyaux gris centraux, vol.1, p.76300

. Sotteville-lès-rouen, ). France, and C. Berjamin, CIC 1415, Centre d'Investigation Clinique, vol.76300

, Rapport au ministre chargé de la Sécurité sociale et au Parlement sur l'évolution des charges et des produits de l'Assurance maladie au titre de 2014. [Improving the quality of the healthcare system and controlling expenses: Proposals from the French Health Insurance Administration for 2014. Report to the Minister of Social Security and to the Parliament on changes to products and costs for the French Health Insurance Administration, CNAMTS. Améliorer la qualité du système de santé et maîtriser les dépenses: propositions de l'Assurance maladie pour, 2013.

G. Fond, C. Lancon, and P. Auquier, Prevalence of major depression in France in the general population and in specific populations from 2000 to 2018: a systematic review of the literature, Presse Med, vol.48, pp.365-75, 2019.

T. Vos, A. D. Flaxman, and M. Naghavi, Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the global burden of disease study 2010, Lancet, vol.380, pp.2163-96, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00921555

H. Autorité-de-santé, Prise en charge des complications évolutives d'un épisode dépressif caractérisé de l'adulte. Recommendations. Avril, Paris: Haute Autorité de Santé, 2007.

A. J. Rush, M. H. Trivedi, and S. R. Wisniewski, Acute and longerterm outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report, AJP, vol.163, pp.1905-1922, 2006.

A. Fekadu, S. C. Wooderson, and K. Markopoulo, What happens to patients with treatment-resistant depression? A systematic review of medium to long term outcome studies, J Affect Disord, vol.116, pp.4-11, 2009.

G. S. Sachs, M. E. Thase, and M. W. Otto, Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD), Biol Psychiatry, vol.53, pp.1028-1070, 2003.

C. Charpeaud, F. Moliere, and M. Bubrovszky, Dépression résistante: les stratégies de changement et d'association de médicaments antidépresseurs, Presse Med, vol.45, pp.329-366, 2016.

O. Doumy, D. Bennabi, and W. El-hage, Dépression résistante: les stratégies de potentialisation

, Presse Med, vol.45, pp.338-387, 2016.

G. Saba, I. Nieto, and R. Bation, Other therapeutic strategies, Presse Med, vol.45, pp.323-355, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01872719

S. Pampallona, P. Bollini, and G. Tibaldi, Patient adherence in the treatment of depression, Br J Psychiatry, vol.180, pp.104-113, 2002.

H. Xh, S. A. Bull, and E. M. Hunkeler, Incidence and duration of side effects and those rated as bothersome with selective serotonin reuptake inhibitor treatment for depression: patient report versus physician estimate, J Clin Psychiatry, vol.65, pp.959-65, 2004.

A. Sauvaget, E. Poulet, and A. Mantovani, The psychiatric neuromodulation unit: implementation and management, J Ect, vol.34, pp.211-220, 2018.
URL : https://hal.archives-ouvertes.fr/halshs-01841240

A. R. Brunoni, G. Tortella, and I. M. Benseñor, Cognitive effects of transcranial direct current stimulation in depression: results from the SELECT-TDCS trial and insights for further clinical trials, J Affect Disord, vol.202, pp.46-52, 2016.

G. D'urso, A. R. Brunoni, and M. P. Mazzaferro, Transcranial direct current stimulation for obsessive-compulsive disorder: a randomized, controlled, partial crossover trial, Depress Anxiety, vol.33, pp.1132-1172, 2016.

M. Mondino, F. Haesebaert, and E. Poulet, Fronto-Temporal transcranial direct current stimulation (tDCS) reduces sourcemonitoring deficits and auditory hallucinations in patients with schizophrenia, Schizophr Res, vol.161, pp.515-521, 2015.

G. D?urso, A. Mantovani, and S. Patti, Transcranial direct current stimulation in obsessive-compulsive disorder, posttraumatic stress disorder, and anxiety disorders, J. Ect, vol.34, pp.172-81, 2018.

A. Sauvaget, B. Trojak, and S. Bulteau, Transcranial direct current stimulation (tDCS) in behavioral and food addiction: a systematic review of efficacy, technical, and methodological issues, Front Neurosci, vol.9, 2015.

G. D'urso, D. Bruzzese, and R. Ferrucci, Transcranial direct current stimulation for hyperactivity and noncompliance in autistic disorder, World J Biol Psychiatry, vol.16, pp.361-367, 2015.

R. Ferrucci, S. Mrakic-sposta, and S. Gardini, Behavioral and neurophysiological effects of transcranial direct current stimulation (tDCS) in fronto-temporal dementia, Front Behav Neurosci, vol.12, 2018.

R. V. Milev, P. Giacobbe, and S. H. Kennedy, CANMAT depression work group. Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 4. neurostimulation treatments, Can J Psychiatry, vol.61, pp.561-75, 2016.

J. P. Lefaucheur, A. Antal, and S. S. Ayache, Evidence-Based guidelines on the therapeutic use of transcranial direct current stimulation (tDCS), Clin Neurophysiol, vol.128, pp.56-92, 2017.

P. Oakes, M. Loukas, and R. J. Oskouian, The neuroanatomy of depression: a review, Clin. Anat, vol.30, pp.44-53, 2017.

A. R. Brunoni, R. Ferrucci, and F. Fregni, Transcranial direct current stimulation for the treatment of major depressive disorder: a summary of preclinical, clinical and translational findings, Prog Neuropsychopharmacol Biol Psychiatry, vol.39, pp.9-16, 2012.

A. R. Brunoni, A. H. Moffa, and F. Fregni, Transcranial direct current stimulation for acute major depressive episodes: meta-analysis of individual patient data, Br J Psychiatry, vol.208, pp.522-553, 2016.

U. G. Kalu, C. E. Sexton, and C. K. Loo, Transcranial direct current stimulation in the treatment of major depression: a meta-analysis, Psychol Med, vol.42, pp.1791-800, 2012.

M. T. Berlim, F. Van-den-eynde, and Z. J. Daskalakis, Clinical utility of transcranial direct current stimulation (tDCS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials, J Psychiatr Res, vol.47, pp.1-7, 2013.

D. Meron, N. Hedger, and M. Garner, Transcranial direct current stimulation (tDCS) in the treatment of depression: systematic review and meta-analysis of efficacy and tolerability, Neurosci Biobehav Rev, vol.57, pp.46-62, 2015.

P. Shiozawa, F. Fregni, and I. M. Benseñor, Transcranial direct current stimulation for major depression: an updated systematic review and meta-analysis, Int J Neuropsychopharmacol, vol.17, issue.9, p.1539, 2014.

D. M. Blumberger, L. C. Tran, and P. B. Fitzgerald, A randomized doubleblind sham-controlled study of transcranial direct current stimulation for treatment-resistant major depression, Front Psychiatry, vol.3, 2012.

U. Palm, C. Schiller, and Z. Fintescu, Transcranial direct current stimulation in treatment resistant depression: a randomized doubleblind, placebo-controlled study, Brain Stimul, vol.5, pp.242-51, 2012.

D. Bennabi, M. Nicolier, and J. Monnin, Pilot study of feasibility of the effect of treatment with tDCS in patients suffering from treatmentresistant depression treated with escitalopram, Clin Neurophysiol, vol.126, pp.1185-1194, 2015.

R. Ferrucci, M. Bortolomasi, and M. Vergari, Transcranial direct current stimulation in severe, drug-resistant major depression, J Affect Disord, vol.118, pp.215-224, 2009.

U. Palm, A. Hasan, and W. Strube, tDCS for the treatment of depression: a comprehensive review, Eur Arch Psychiatry Clin Neurosci, vol.266, pp.681-94, 2016.

P. S. Boggio, S. P. Rigonatti, and R. B. Ribeiro, A randomized, doubleblind clinical trial on the efficacy of cortical direct current stimulation for the treatment of major depression, Int J Neuropsychopharmacol, vol.11, pp.249-54, 2008.

A. R. Brunoni, B. Sampaio-junior, and A. H. Moffa, The escitalopram versus electric current therapy for treating depression clinical study (ELECT-TDCS): rationale and study design of a non-inferiority, triple-arm, placebo-controlled clinical trial, Sao Paulo Med J, vol.133, pp.252-63, 2015.

C. K. Loo, A. Alonzo, and D. Martin, Transcranial direct current stimulation for depression: 3-week, randomised, sham-controlled trial, Br J Psychiatry, vol.200, pp.52-61, 2012.

C. Dondé, A. Amad, and I. Nieto, Transcranial direct-current stimulation (tDCS) for bipolar depression: a systematic review on, Prog Neuropsychopharmacol Biol Psychiatry, vol.78, pp.123-154, 2017.

G. D'urso, B. Dell'osso, and R. Rossi, Clinical predictors of acute response to transcranial direct current stimulation (tDCS) in major depression, J Affect Disord, vol.219, pp.25-30, 2017.

B. X. Tran, G. H. Ha, and G. T. Vu, Indices of change, expectations, and popularity of biological treatments for major depressive disorder between 1988 and 2017: a Scientometric analysis, Int J Environ Res Public Health, vol.16, p.2255, 2019.

B. Dell'osso, C. Dobrea, and C. Arici, Augmentative transcranial direct current stimulation (tDCS) in poor Responder depressed patients: a follow-up study, CNS Spectr, vol.19, pp.347-54, 2014.

, Dsm-5: diagnostic and statistical manual of mental disorders, 2013.

C. Roussel, C. Carbonneil, and A. A. , Participants of Giens XXXI, round table No. 4. organisational impact: definition and assessment methods for medical devices, Therapie, vol.71, pp.69-96, 2016.

A. Manca, N. Hawkins, and M. J. Sculpher, Estimating mean QALYs in trialbased cost-effectiveness analysis: the importance of controlling for baseline utility, Health Econ, vol.14, pp.487-96, 2005.

H. Autorité-de-santé, Choices in methods for economic evaluation, 2012.

H. A. Glick, Sample size and power for cost-effectiveness analysis (Part 1), Pharmacoeconomics, vol.29, pp.189-98, 2011.

A. R. Brunoni, R. Ferrucci, and M. Bortolomasi, Interactions between transcranial direct current stimulation (tDCS) and pharmacological interventions in the major depressive episode: findings from a naturalistic study, Eur Psychiatry, vol.28, pp.356-61, 2013.

R. Faria, M. Gomes, and D. Epstein, A guide to handling missing data in cost-effectiveness analysis conducted within randomised controlled trials, Pharmacoeconomics, vol.32, pp.1157-70, 2014.

A. Gray, P. Clarke, and J. Wolstenholme, Applied methods of costeffectiveness analysis in health care, 2011.

K. Nguyen and L. G. Gordon, Cost-Effectiveness of repetitive transcranial magnetic stimulation versus antidepressant therapy for treatment-resistant depression, Value in Health, vol.18, pp.597-604, 2015.

J. Voigt, L. Carpenter, and A. Leuchter, Cost effectiveness analysis comparing repetitive transcranial magnetic stimulation to antidepressant medications after a first treatment failure for major depressive disorder in newly diagnosed patients -A lifetime analysis, PLoS One, vol.12, p.186950, 2017.

H. Ghiasvand, M. Moradi-joo, and N. Abolhassani, Economic evaluation of resistant major depressive disorder treatment in Iranian population: a comparison between repetitive transcranial magnetic stimulation with electroconvulsive, Med J Islam Repub Iran, vol.30, 2016.

Y. J. Zhao, P. C. Tor, and A. L. Khoo, Cost-Effectiveness modeling of repetitive transcranial magnetic stimulation compared to electroconvulsive therapy for treatment-resistant depression in Singapore, Neuromodulation, vol.21, pp.376-82, 2018.

F. Etcheverrigaray, S. Bulteau, and L. O. Machon, Hospital production cost of repetitive transcranial magnetic stimulation (rTMS) in the treatment of depression, Rev Epidemiol Sante Publique, vol.63, pp.268-74, 2015.

A. Sauvaget, A. Tostivint, and F. Etcheverrigaray, Hospital production cost of transcranial direct current stimulation (tDCS) in the treatment of depression, Neurophysiol Clin, vol.49, pp.11-18, 2019.
URL : https://hal.archives-ouvertes.fr/inserm-01953524

D. Mcloughlin, A. Mogg, and S. Eranti, The clinical effectiveness and cost of repetitive transcranial magnetic stimulation versus electroconvulsive therapy in severe depression: a multicentre pragmatic randomised controlled trial and economic analysis, Health Technol Assess, vol.11, pp.1-54, 2007.

D. M. Martin, A. Alonzo, and K. Ho, Continuation transcranial direct current stimulation for the prevention of relapse in major depression, J Affect Disord, vol.144, pp.274-282, 2013.

L. Valiengo, I. M. Benseñor, and A. C. Goulart, The sertraline versus electrical current therapy for treating depression clinical study (select-TDCS): results of the crossover and follow-up phases, Depress Anxiety, vol.30, pp.646-53, 2013.

G. D'urso, A. Mantovani, and M. Micillo, Transcranial direct current stimulation and cognitive-behavioral therapy: evidence of a synergistic effect in treatment-resistant depression, Brain Stimul, vol.6, pp.465-472, 2013.